Linkedin-in Facebook-f
Our Portfolio Companies
  • About Us
    • About Us
    • Staff and Board of Directors
  • Industry & Investors
    • Partnership Models
    • Venture Funds
    • Courses
  • Success Stories
  • Media Center
    • News
    • Podcasts
    • Press Releases
  • Faculty & Researchers
  • Contact Us
  • About Us
    • About Us
    • Staff and Board of Directors
  • Industry & Investors
    • Partnership Models
    • Venture Funds
    • Courses
  • Success Stories
  • Media Center
    • News
    • Podcasts
    • Press Releases
  • Faculty & Researchers
  • Contact Us
Briefcase Loading...

Hebrew University Researchers to Collaborate With Grail

  • June 12, 2018

Strategic partnership will focus on generating methylation data as part of ongoing research for early cancer detection

Today, Yissum, the Technology Transfer Company of The Hebrew University of Jerusalem, announced a strategic collaboration with GRAIL, Inc., a healthcare company whose mission is to detect cancer early, when it can be cured. Under the agreement, GRAIL will sponsor a research program led by Professor Yuval Dor of The Hebrew University’s Faculty of Medicine.

Professor Dor, working with Dr. Ruth Shemer, Dr. Tommy Kaplan, and Professor Benjamin Glaser from Hadassah Medical Center, is creating a method to determine the tissue origins of circulating DNA, using epigenetic “identity marks” from the DNA that are typical to each cell type, termed DNA methylation.

In the new partnership, GRAIL and the Hebrew University team will collaborate to generate methylation data from multiple cell types to understand how to interpret the source of bloodbased signals.

Dr. Yaron Daniely, CEO and President of Yissum, welcomed the agreement. “We are excited to enter this collaboration with GRAIL, which underscores the promise of Professor Dor’s research at Hebrew University and supports our vision of bettering the lives of people around the world through collaborations between industry and academic organizations.”

Contact: Estee Yaari, Yissum, [email protected], +972 50 200 7072

About Yissum
Yissum is the technology transfer company of The Hebrew University of Jerusalem. Founded in 1964, it is the third company of its kind to be established and serves as a bridge between cutting-edge academic research and a global community of entrepreneurs, investors, and industry. Yissum’s mission is to benefit society by converting extraordinary innovations and transformational technologies into commercial solutions that address our most urgent global challenges. Yissum has registered over 10,000 patents covering 2,800 inventions; licensed over 900 technologies and has spun out more than 130 companies. Yissum’s business partners span the globe and include companies such as Boston Scientific, Google, ICL, Intel, Johnson & Johnson, Merck, Microsoft, Novartis and many more. For further information please visit www.yissum.co.il

Latest

Startup Vitalunga creates novel oral drug to enable disease-free aging; preclinical studies expected to begin in near future

May 25, 2022
The Hebrew University Portfolio Company addresses modern medicine’s number one problem: extending lifespan without disease and has the potential to improve quality of life for the world’s rapidly growing aging population….

Hebrew University Team Announces Creation of Shape-Shifting Pasta to Revolutionize the Packaging Industry

March 31, 2022
The pasta, which transforms from flat to popular shapes upon boiling, is highly unique and could cut down on packaging costs and carbon dioxide emissions for manufacturers….

Yissum Technology Transfer Announces 15 New Companies

January 20, 2022
The new batch of promising startups backed by The Hebrew University of Jerusalem’s Technology Transfer includes next-generation tech spanning MRNA, genetics, delivery methods, and other pharma advancements, alongside next-gen solar technology….
ADDRESS

Hi-Tech Park, Edmond J. Safra
Campus, Bungalow 2.6
Givat-Ram, Jerusalem
P.O. Box 39135
91390 Israel

CONTACT US
  • Phone: +972-2-658-6688
  • Fax: +972-2-658-6689
  • Email: [email protected]
FOLLOW US
Twitter Linkedin-in Facebook-f Youtube
COPYRIGHT
Twitter Linkedin-in Facebook-f Youtube
  • About Us
    • About Us
    • Staff and Board of Directors
  • Industry & Investors
    • Partnership Models
    • Venture Funds
    • Courses
  • Success Stories
  • Media Center
    • News
    • Podcasts
    • Press Releases
  • Faculty & Researchers
  • Contact Us
Search Our Technologies
Find a Research Expert
Our Portfolio Companies
Briefcase Loading...